Physician profile
Michael A Spinelli
NPI 1568629814
$38,744.00
in general payments reported to CMS, 2019-2025
25 companies · $10K in 2025
The $10K reported for 2025 was more than what 81% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,466 · 2020: $1,408 · 2021: $2,222 · 2022: $5,699 · 2023: $5,495 · 2024: $12K · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14K · Consulting Fee: $8,644 · Travel and Lodging: $4,901 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $800 · Education: $5.33.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,599.25 |
| Consulting Fee | $8,643.75 |
| Travel and Lodging | $4,900.50 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $800.00 |
| Education | $5.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $13,164.83 | 2019-2025 | Aveir, Thoratec Heartmate 3 Lvas Implant Kit, Gallant |
| Biotronik INC. | $11,781.90 | 2019-2025 | Acticor 7 Vr-T Dx, Edora 8 Dr-T, Rivacor 7 Dr-T |
| Medtronic, INC. | $6,764.19 | 2021-2025 | Linq II, Cobalt Dr Mri Surescan, Evera Mri Xt Dr Surescan |
| Biosense Webster, INC. | $2,355.32 | 2020-2025 | Qdot Micro Catheter, Carto 3, Qdot Micro |
| Boston Scientific Corporation | $2,051.29 | 2019-2025 | Farapulse, General - Therapies, Watchman Flx |
| Philips North America LLC | $602.73 | 2021-2025 | (Am5) Lead Management, Lm Undivided, (9274) Lld |
| Impulse Dynamics (USA) INC. | $568.83 | 2020-2024 | Optimizer |
| Medtronic Vascular, INC. | $363.90 | 2019-2020 | |
| Kestra Medical Technology Services, INC. | $157.53 | 2023-2024 | Assure Wcd |
| Atricure, INC. | $142.11 | 2021 | |
| Zoll Respicardia, INC. | $141.73 | 2020 | |
| Cordis US Corp. | $124.86 | 2024-2025 | Mynx Control Venous, Mynx Venous Vcd |
| Boehringer Ingelheim Pharmaceuticals, INC. | $106.63 | 2019 | |
| Cardiva Medical, INC. | $79.00 | 2020-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs |
| Sanofi-Aventis U.S. LLC | $58.11 | 2019-2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $56.63 | 2019 | |
| Lundbeck LLC | $54.90 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $37.13 | 2019 | |
| Edwards Lifesciences Corporation | $25.78 | 2019 | |
| Amgen INC. | $24.04 | 2019 | |
| Irhythm Technologies, INC. | $18.81 | 2019 | |
| Pfizer INC. | $17.04 | 2019 | |
| Novartis Pharmaceuticals Corporation | $16.33 | 2019 | |
| Amarin Pharma, INC. | $15.38 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $15.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Spinelli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.